American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting - Results from #20

Viewing 21-38 of 38 articles

ASTRO 2021: Defining Racial Disparities Across the Prostate Cancer Disease Continuum in an Equal Access-to-Care Setting Within the Nation's Largest Healthcare Network

ASTRO 2021: Local Control in Tumor-Targeted Dose Escalation for Localized Prostate Cancer

ASTRO 2021: Focal Therapy as Alternative for Whole-Gland Therapy for Intermediate-Risk Prostate Cancer

ASTRO 2021: Optimizing Hypofractionation: IMRT and SBRT

ASTRO 2021: Conventional vs Hypofractionated Radiation for High Risk Prostate Cancer Patients (CHIRP): 24 months Patient Reported Quality of Life Outcomes of the Randomized Phase II CHIRP Trial

ASTRO 2021: RTOG 0926: Phase II Protocol Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemo Following a Thorough Transurethral Surgical Re-Staging

ASTRO 2021: Elective Nodal Irradiation with a Simultaneous Hypofractionated Integrated Prostate Boost for Localized High-Risk Prostate Cancer: Long-Term Results From a Prospective Clinical Trial

ASTRO 2021: Detection Failure Patterns Using Advanced Imaging in Patients with Biochemical Recurrence Following Low Dose Rate Brachytherapy for Prostate Cancer

ASTRO 2021: Molecular Imaging with Fluciclovine PET

ASTRO 2021: Individual Patient Data Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium: Impact of ADT Use and Duration with Definitive Radiotherapy for Localized Prostate Cancer

ASTRO 2021: Controversies in the Management of Muscle-Invasive Bladder Cancer

ASTRO 2021: Current and Future Management Paradigms for Metastatic Castrate-Resistant Prostate Cancer

ASTRO 2021: Newly Diagnosed Oligometastatic Prostate Cancer: Where Should We Focus the Beam?

ASTRO 2021: Can We Cure Oligorecurrent Prostate Cancer? You May Be Surprised!

ASTRO 2021: Is Metastasis-Directed Therapy the Wave of the Future in Oligo-mCRPC?

ASTRO 2021: Systemic Therapy for Very High Risk to Oligometastatic Prostate Cancer

ASTRO 2021: Radiation Therapy for Very High Risk to Oligometastatic Prostate Cancer

ASTRO 2021: NCCN Guidelines for Radiation Therapy and Prostate Cancer: Updates and Controversies

1
2